Havunen, R., Kalliokoski, R., Siurala, M., Sorsa, S., Santos, J. M., Cervera-Carrascon, V., . . . Hemminki, A. (2021). Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1. Cells.
Chicago Style CitationHavunen, Riikka, Riikka Kalliokoski, Mikko Siurala, Suvi Sorsa, João M. Santos, Victor Cervera-Carrascon, Marjukka Anttila, i Akseli Hemminki. "Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective As a Single Agent and in Combination With Immune Checkpoint Inhibitor Anti-PD-1." Cells 2021.
Cita MLAHavunen, Riikka, et al. "Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective As a Single Agent and in Combination With Immune Checkpoint Inhibitor Anti-PD-1." Cells 2021.